Medications

Zurampic approved for gout

(HealthDay)—Zurampic (lesinurad) has been approved by the U.S. Food and Drug Administration to control blood levels of uric acid associated with gout.

Arthritis & Rheumatism

Drug combination benefits patients with tophaceous gout

The drug lesinurad in combination with febuxostat was better at lowering blood levels of urate than febuxostat alone in a phase III clinical trial of 324 patients with tophaceous gout. Over 12 months, significantly more patients ...

Arthritis & Rheumatism

Gout linked to increased hip fracture risk in women

(HealthDay)—For women, a history of gout is associated with increased risk of hip fracture, according to a study published online Jan. 28 in Arthritis & Rheumatology.

Arthritis & Rheumatism

Prevalence of gout increases with increasing BMI

(HealthDay) -- Having an increased body mass index (BMI) correlates with increased prevalence of gout in adults, according to study published online July 6 in Arthritis Care & Research.

Arthritis & Rheumatism

Study finds gout drug may reduce risk of death

(Boston)—In a recently to be published study in Annals of the Rheumatic Diseases, researchers have found the use of the drug allopurinol was associated with a reduced risk of death in hyperuricemic (gout) patients. The ...

Arthritis & Rheumatism

Patients with sleep apnea have increased gout risk

(HealthDay)—Patients with obstructive sleep apnea (OSA) are at higher risk for developing gout than patients without OSA for more than a year after diagnosis, according to a study published in the January issue of Arthritis ...

page 8 from 12